The Department of Experimental and Clinical Pharmacology (ECP) is at the forefront of the emerging discipline of experimental pharmacotherapeutics, providing national and international leadership in individualized medicine through prominent research and an excellent graduate program.
Faculty Spotlight
Lisa Coles, MS, PhD, is the Associate Director of Clinical Pharmacology and Pharmacometrics in the Center for Orphan Drug Research (CODR). She uses modeling and pharmacometrics to address a range of issues related to seizures, seizure emergencies, traumatic brain injury (TBI), and epilepsy.
Read more about Dr. Coles' career and her work on predicting and treating seizure activity in the Fall 2023 issue of the ECP Gazette (.pdf).
ECP Clinical and Translational Research
This cross-disciplinary paradigm translates basic scientific discoveries into safe and effective therapeutic uses by providers and patients, through laboratory experiments and clinical studies. Clinical data can also prompt new questions and investigations, leading back to the bench and beginning a new cycle of translational research.
News
Assistant professor Shen Cheng, PhD, has joined the College of Pharmacy’s Department of Experimental and Clinical Pharmacology (ECP).
ECP alumnus Vijay Ivaturi, PhD ('10), is the new president-elect of the International Society of Pharmacometrics (ISoP). He will serve a one-year term as President-Elect prior to assuming the role of President in 2024.
On June 15th and 16th, the UMN College of Pharmacy hosted 21 pharmacists from the 2023 cohort of the Applied Pharmacogenomics for the Healthcare Workforce program for a workshop targeting pharmacists working in rural and/or underserved communities.
Program to catalyze and support adoption of pharmacogenomics on a national scale.
Ahmar U. Zaidi, MD, Medical Director, Clinical Development, Sickle Cell Disease Program at Agios Pharmaceuticals presented "The Sickle Caste: From a Single Mutation to Victimization and the Road Back".
The University of Minnesota College of Pharmacy is proud to host the nation's first Project ECHO (Extension for Community Healthcare Outcomes) program focused on pharmacogenomics-informed clinical care. Pharmacogenomics (PGx) ECHO launched in October 2021 and focuses on improving a health professional’s confidence in utilizing PGx in patient care by providing case-based education and consultation through telementoring.